The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Edible Vaccine Market Research Report 2025
Synopsis
The global Edible Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Edible Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Edible Vaccine.
Report Scope
The Edible Vaccine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Edible Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Edible Vaccine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
Sanofi
Merck
Merial
Santa Cruz Animal Health
Ceva
Segment by Type
Inactivated Vaccines
Others
Segment by Application
Medical Care
Livestock
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Edible Vaccine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Edible Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Edible Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Edible Vaccine.
Report Scope
The Edible Vaccine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Edible Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Edible Vaccine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
Sanofi
Merck
Merial
Santa Cruz Animal Health
Ceva
Segment by Type
Inactivated Vaccines
Others
Segment by Application
Medical Care
Livestock
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Edible Vaccine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Edible Vaccine Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Inactivated Vaccines
1.2.3 Others
1.3 Market by Application
1.3.1 Global Edible Vaccine Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Medical Care
1.3.3 Livestock
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Edible Vaccine Market Perspective (2019-2030)
2.2 Edible Vaccine Growth Trends by Region
2.2.1 Global Edible Vaccine Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Edible Vaccine Historic Market Size by Region (2019-2024)
2.2.3 Edible Vaccine Forecasted Market Size by Region (2025-2030)
2.3 Edible Vaccine Market Dynamics
2.3.1 Edible Vaccine Industry Trends
2.3.2 Edible Vaccine Market Drivers
2.3.3 Edible Vaccine Market Challenges
2.3.4 Edible Vaccine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Edible Vaccine Players by Revenue
3.1.1 Global Top Edible Vaccine Players by Revenue (2019-2024)
3.1.2 Global Edible Vaccine Revenue Market Share by Players (2019-2024)
3.2 Global Edible Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Edible Vaccine Revenue
3.4 Global Edible Vaccine Market Concentration Ratio
3.4.1 Global Edible Vaccine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Edible Vaccine Revenue in 2023
3.5 Edible Vaccine Key Players Head office and Area Served
3.6 Key Players Edible Vaccine Product Solution and Service
3.7 Date of Enter into Edible Vaccine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Edible Vaccine Breakdown Data by Type
4.1 Global Edible Vaccine Historic Market Size by Type (2019-2024)
4.2 Global Edible Vaccine Forecasted Market Size by Type (2025-2030)
5 Edible Vaccine Breakdown Data by Application
5.1 Global Edible Vaccine Historic Market Size by Application (2019-2024)
5.2 Global Edible Vaccine Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Edible Vaccine Market Size (2019-2030)
6.2 North America Edible Vaccine Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Edible Vaccine Market Size by Country (2019-2024)
6.4 North America Edible Vaccine Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Edible Vaccine Market Size (2019-2030)
7.2 Europe Edible Vaccine Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Edible Vaccine Market Size by Country (2019-2024)
7.4 Europe Edible Vaccine Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Edible Vaccine Market Size (2019-2030)
8.2 Asia-Pacific Edible Vaccine Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Edible Vaccine Market Size by Region (2019-2024)
8.4 Asia-Pacific Edible Vaccine Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Edible Vaccine Market Size (2019-2030)
9.2 Latin America Edible Vaccine Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Edible Vaccine Market Size by Country (2019-2024)
9.4 Latin America Edible Vaccine Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Edible Vaccine Market Size (2019-2030)
10.2 Middle East & Africa Edible Vaccine Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Edible Vaccine Market Size by Country (2019-2024)
10.4 Middle East & Africa Edible Vaccine Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Detail
11.1.2 GSK Business Overview
11.1.3 GSK Edible Vaccine Introduction
11.1.4 GSK Revenue in Edible Vaccine Business (2019-2024)
11.1.5 GSK Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Detail
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Edible Vaccine Introduction
11.2.4 Sanofi Revenue in Edible Vaccine Business (2019-2024)
11.2.5 Sanofi Recent Development
11.3 Merck
11.3.1 Merck Company Detail
11.3.2 Merck Business Overview
11.3.3 Merck Edible Vaccine Introduction
11.3.4 Merck Revenue in Edible Vaccine Business (2019-2024)
11.3.5 Merck Recent Development
11.4 Merial
11.4.1 Merial Company Detail
11.4.2 Merial Business Overview
11.4.3 Merial Edible Vaccine Introduction
11.4.4 Merial Revenue in Edible Vaccine Business (2019-2024)
11.4.5 Merial Recent Development
11.5 Santa Cruz Animal Health
11.5.1 Santa Cruz Animal Health Company Detail
11.5.2 Santa Cruz Animal Health Business Overview
11.5.3 Santa Cruz Animal Health Edible Vaccine Introduction
11.5.4 Santa Cruz Animal Health Revenue in Edible Vaccine Business (2019-2024)
11.5.5 Santa Cruz Animal Health Recent Development
11.6 Ceva
11.6.1 Ceva Company Detail
11.6.2 Ceva Business Overview
11.6.3 Ceva Edible Vaccine Introduction
11.6.4 Ceva Revenue in Edible Vaccine Business (2019-2024)
11.6.5 Ceva Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Edible Vaccine Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Inactivated Vaccines
Table 3. Key Players of Others
Table 4. Global Edible Vaccine Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Edible Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Edible Vaccine Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Edible Vaccine Market Share by Region (2019-2024)
Table 8. Global Edible Vaccine Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Edible Vaccine Market Share by Region (2025-2030)
Table 10. Edible Vaccine Market Trends
Table 11. Edible Vaccine Market Drivers
Table 12. Edible Vaccine Market Challenges
Table 13. Edible Vaccine Market Restraints
Table 14. Global Edible Vaccine Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Edible Vaccine Market Share by Players (2019-2024)
Table 16. Global Top Edible Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Edible Vaccine as of 2023)
Table 17. Ranking of Global Top Edible Vaccine Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Edible Vaccine Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Edible Vaccine Product Solution and Service
Table 21. Date of Enter into Edible Vaccine Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Edible Vaccine Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Edible Vaccine Revenue Market Share by Type (2019-2024)
Table 25. Global Edible Vaccine Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Edible Vaccine Revenue Market Share by Type (2025-2030)
Table 27. Global Edible Vaccine Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Edible Vaccine Revenue Market Share by Application (2019-2024)
Table 29. Global Edible Vaccine Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Edible Vaccine Revenue Market Share by Application (2025-2030)
Table 31. North America Edible Vaccine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Edible Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Edible Vaccine Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Edible Vaccine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Edible Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Edible Vaccine Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Edible Vaccine Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Edible Vaccine Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Edible Vaccine Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Edible Vaccine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Edible Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Edible Vaccine Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Edible Vaccine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Edible Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Edible Vaccine Market Size by Country (2025-2030) & (US$ Million)
Table 46. GSK Company Detail
Table 47. GSK Business Overview
Table 48. GSK Edible Vaccine Product
Table 49. GSK Revenue in Edible Vaccine Business (2019-2024) & (US$ Million)
Table 50. GSK Recent Development
Table 51. Sanofi Company Detail
Table 52. Sanofi Business Overview
Table 53. Sanofi Edible Vaccine Product
Table 54. Sanofi Revenue in Edible Vaccine Business (2019-2024) & (US$ Million)
Table 55. Sanofi Recent Development
Table 56. Merck Company Detail
Table 57. Merck Business Overview
Table 58. Merck Edible Vaccine Product
Table 59. Merck Revenue in Edible Vaccine Business (2019-2024) & (US$ Million)
Table 60. Merck Recent Development
Table 61. Merial Company Detail
Table 62. Merial Business Overview
Table 63. Merial Edible Vaccine Product
Table 64. Merial Revenue in Edible Vaccine Business (2019-2024) & (US$ Million)
Table 65. Merial Recent Development
Table 66. Santa Cruz Animal Health Company Detail
Table 67. Santa Cruz Animal Health Business Overview
Table 68. Santa Cruz Animal Health Edible Vaccine Product
Table 69. Santa Cruz Animal Health Revenue in Edible Vaccine Business (2019-2024) & (US$ Million)
Table 70. Santa Cruz Animal Health Recent Development
Table 71. Ceva Company Detail
Table 72. Ceva Business Overview
Table 73. Ceva Edible Vaccine Product
Table 74. Ceva Revenue in Edible Vaccine Business (2019-2024) & (US$ Million)
Table 75. Ceva Recent Development
Table 76. Research Programs/Design for This Report
Table 77. Key Data Information from Secondary Sources
Table 78. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Edible Vaccine Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Edible Vaccine Market Share by Type: 2023 VS 2030
Figure 3. Inactivated Vaccines Features
Figure 4. Others Features
Figure 5. Global Edible Vaccine Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Edible Vaccine Market Share by Application: 2023 VS 2030
Figure 7. Medical Care Case Studies
Figure 8. Livestock Case Studies
Figure 9. Others Case Studies
Figure 10. Edible Vaccine Report Years Considered
Figure 11. Global Edible Vaccine Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Edible Vaccine Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Edible Vaccine Market Share by Region: 2023 VS 2030
Figure 14. Global Edible Vaccine Market Share by Players in 2023
Figure 15. Global Top Edible Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Edible Vaccine as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Edible Vaccine Revenue in 2023
Figure 17. North America Edible Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Edible Vaccine Market Share by Country (2019-2030)
Figure 19. United States Edible Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Edible Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Edible Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Edible Vaccine Market Share by Country (2019-2030)
Figure 23. Germany Edible Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Edible Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Edible Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Edible Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Edible Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Edible Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Edible Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Edible Vaccine Market Share by Region (2019-2030)
Figure 31. China Edible Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Edible Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Edible Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Edible Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Edible Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Edible Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Edible Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Edible Vaccine Market Share by Country (2019-2030)
Figure 39. Mexico Edible Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Edible Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Edible Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Edible Vaccine Market Share by Country (2019-2030)
Figure 43. Turkey Edible Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Edible Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. GSK Revenue Growth Rate in Edible Vaccine Business (2019-2024)
Figure 46. Sanofi Revenue Growth Rate in Edible Vaccine Business (2019-2024)
Figure 47. Merck Revenue Growth Rate in Edible Vaccine Business (2019-2024)
Figure 48. Merial Revenue Growth Rate in Edible Vaccine Business (2019-2024)
Figure 49. Santa Cruz Animal Health Revenue Growth Rate in Edible Vaccine Business (2019-2024)
Figure 50. Ceva Revenue Growth Rate in Edible Vaccine Business (2019-2024)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
